Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

SCPH holding history

scPharmaceuticals Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SCPH overviewAll 13F holders of SCPHFull Q4 2025 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of SCPH by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−2,176,970−100.0%Sold outHolders
Q3 20252,176,970$12.3M<0.1%+341,321+18.6%AddedHolders
Q2 20251,835,649$6.99M<0.1%−157,111−7.9%ReducedHolders
Q1 20251,992,760$5.24M<0.1%−115,697−5.5%ReducedHolders
Q4 20242,108,457$7.46M<0.1%+399,511+23.4%AddedHolders
Q3 20241,708,946$7.79M<0.1%+322,750+23.3%AddedHolders
Q2 20241,386,196$6.03M<0.1%+16,360+1.2%AddedHolders
Q1 20241,369,836$6.88M<0.1%−520.0%ReducedHolders
Q4 20231,369,888$8.59M<0.1%+150,871+12.4%AddedHolders
Q3 20231,219,017$8.68M<0.1%+26,011+2.2%AddedHolders
Q2 20231,193,006$12.2M<0.1%+193,039+19.3%AddedHolders
Q1 2023999,967$9.07M<0.1%+122,959+14.0%AddedHolders
Q4 2022877,008$6.29M<0.1%+260,450+42.2%AddedHolders
Q3 2022616,558$4.02M<0.1%00.0%UnchangedHolders
Q2 2022616,558$2.97M<0.1%00.0%UnchangedHolders
Q1 2022616,558$3.50M<0.1%00.0%UnchangedHolders
Q4 2021616,558$3.10M<0.1%−490−0.1%ReducedHolders
Q3 2021617,048$4.10M<0.1%+8,100+1.3%AddedHolders
Q2 2021608,948$3.72M<0.1%−34,507−5.4%ReducedHolders
Q1 2021643,455$4.28M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.